Again, low levels of BCAT1 is a good prognostic marker for HCC and oral supplementation with branched chain amino acids has been shown to reduce the risk of liver cancer in cirrhotic patients44,45. The gene discussed is BCAT1; the disease is hepatocellular carcinoma.